Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Hûn Gangliosidosis Type 1 In Shiba Inu (GM1-SI)
Discover the importance of the DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs, a critical genetic screening to ensure your pet’s health. GM1 gangliosidosis is a rare but severe inherited disorder affecting the nervous system, leading to progressive neurological decline. Early DNA testing helps breeders and owners identify carriers and affected dogs, preventing the spread of this debilitating condition. By using a reliable GM1 DNA test, you can make informed breeding decisions and protect future generations of Shiba Inu. Ensure your dog’s well-being with accurate genetic screening for Gangliosidosis Type 1 today. Prioritize health and longevity with this essential DNA test for Shiba Inu.
Ofkoarting: GM1-SI
Analysearre mutaasje: GLB1 c.1649delC
Erfskip: Autosomaal recessyf
Acronym
GM1-SI
Observearre frekwinsje
Klinyske earnst
Clinical klassifikaasje
Neurologyske sykten
Analysearre mutaasje
GLB1 c.1649delC
p.(P550Rfs*50)
p.(P550Rfs*50)
Mode fan erfskip
Autosomaal recessyf (Complete)
Test gearfetting:
The DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs helps identify carriers and affected individuals of this genetic disorder. GM1 gangliosidosis is a rare, inherited lysosomal storage disease that causes progressive neurological decline. Early detection through genetic testing allows breeders to make informed decisions to reduce the risk of passing the condition to offspring. This test is crucial for maintaining the health and longevity of the Shiba Inu breed. Responsible breeding practices rely on such DNA tests to prevent the spread of GM1 in the population.
Beskikber út it pakket: Basic
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Kies it pakket dat it bêste past by jo fokken of sûnensstrategy fan jo bisten.
Understanding Gangliosidosis Type 1 (GM1) in Shiba Inu
Gangliosidosis Type 1, commonly referred to as GM1, is a genetic disorder that affects the metabolism of certain lipids, specifically gangliosides, in the brain and nervous system of dogs. This condition is particularly noted in the Shiba Inu breed. GM1 is caused by a deficiency in the enzyme beta-galactosidase, which leads to the accumulation of gangliosides in the cells, resulting in neurological dysfunction and a range of clinical symptoms.
Clinical Symptoms of GM1
The symptoms of Gangliosidosis Type 1 typically manifest between the ages of three to six months. Affected dogs may exhibit a variety of neurological signs, including but not limited to, ataxia (loss of coordination), tremors, seizures, and a decline in cognitive functions. As the disease progresses, dogs may experience muscle weakness, difficulty walking, and a general decline in their quality of life. In severe cases, GM1 can lead to premature death, often occurring within the first few years of life.
Diagnosis of GM1
Diagnosis of Gangliosidosis Type 1 is primarily achieved through genetic testing that identifies mutations in the gene responsible for producing the beta-galactosidase enzyme. While clinical signs can suggest the presence of GM1, definitive diagnosis through a DNA test is crucial for confirming the disorder. Early detection allows for better management of the dog's health and can guide owners in making informed decisions about their pet's care.
Treatment and Management
Currently, there is no cure for Gangliosidosis Type 1, and treatment focuses on managing the symptoms and improving the quality of life for affected dogs. Supportive care may include physical therapy, pain management, and nutritional support. Regular veterinary check-ups are essential to monitor the progression of the disease and to address any arising complications.
Importance of Genetic Testing
Genetic testing for GM1 is critical for breeders and dog owners. By identifying carriers of the disease, responsible breeding practices can be implemented to reduce the incidence of GM1 in future generations. Awareness and understanding of this condition are vital in promoting the health and longevity of the Shiba Inu breed.
Ras erkend foar de test: Gangliosidosis Type 1 In Shiba Inu (GM1-SI)
- Shiba Inu
🧬 Interpretation of genotypes GM1-SI
Genotype
Status
🟡 N/N
Non-carrier - Gjin risiko
🟡 N/GM1-SI
Carrier - Gjin risiko
❌ GM1-SI/GM1-SI
Beynfloede - At Risk
FAQ: begripe de ynterpretaasje
Is in "Carrier" serieus?
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
Wat as in bist "oandwaande" is?
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Wêrom binne d'r ferskillen tusken manlik / froulik?
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
Foarsizze Offspring
N/N (non-drager)
N/GM1-SI (Carrier)
GM1-SI/GM1-SI (Beynfloede)
DNA Test FAQ
Wat detektearret dizze DNA-test?
This DNA test detects the mutation associated with Gangliosidosis Type 1 In Shiba Inu (GM1-SI) in order to identify clear, carrier, or at-risk animals.
Wêrom testje in fokdier?
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
Wat is de erflike modus fan dizze test?
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
Hokker mutaasje wurdt analysearre yn dizze test?
This test analyses the mutation GLB1 c.1649delC.
Is in dragerdier needsaaklik beynfloede?
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
References
Yamato O, Endoh D, Kobayashi A, Masuoka Y, Yonemura M, Hatakeyama A, Satoh H, Tajima M, Yamasaki M, Maede Y. A novel mutation in the gene for canine acid beta-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J Inherit Metab Dis. 2002 Oct;25(6):525-6. doi: 10.1023/a:1021280007739.